Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lane

Showing results (441-450 of 493) with videos related to

Pageof 50
Sort By:
Iscience|December 29, 2023
Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron developmentJames Hennegan, Aled H Bryant, Lauren Griffiths, et al.
Immunity|March 20, 2012
Rank signaling links the development of invariant γδ T cell progenitors and Aire(+) medullary epitheliumNatalie A Roberts, Andrea J White, William E Jenkinson, et al.
JCO Precision Oncology|May 18, 2026
Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
JCO Precision Oncology|December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
NPJ Breast Cancer|January 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancerGloria V Echeverria, Shirong Cai, Yizheng Tu, et al.
Frontiers in Oncology|November 9, 2023
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerBikash Panthi, Rania M Mohamed, Beatriz E Adrada, et al.
Journal of Parkinson'S Disease|May 3, 2024
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation ProtocolMarie-Louise Zeissler, Nikul Bakshi, Michèle Bartlett, et al.
NPJ Breast Cancer|November 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancerMary S Guirguis, Beatriz E Adrada, Clinton Yam, et al.
Cancers|March 28, 2025
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerZhan Xu, Zijian Zhou, Jong Bum Son, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Pageof 50

Showing results (441-450 of 493) with videos related to

Sort By:
Pageof 50
Iscience|December 29, 2023
Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron developmentJames Hennegan, Aled H Bryant, Lauren Griffiths, et al.
Immunity|March 20, 2012
Rank signaling links the development of invariant γδ T cell progenitors and Aire(+) medullary epitheliumNatalie A Roberts, Andrea J White, William E Jenkinson, et al.
JCO Precision Oncology|May 18, 2026
Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
JCO Precision Oncology|December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
NPJ Breast Cancer|January 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancerGloria V Echeverria, Shirong Cai, Yizheng Tu, et al.
Frontiers in Oncology|November 9, 2023
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerBikash Panthi, Rania M Mohamed, Beatriz E Adrada, et al.
Journal of Parkinson'S Disease|May 3, 2024
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation ProtocolMarie-Louise Zeissler, Nikul Bakshi, Michèle Bartlett, et al.
NPJ Breast Cancer|November 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancerMary S Guirguis, Beatriz E Adrada, Clinton Yam, et al.
Cancers|March 28, 2025
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerZhan Xu, Zijian Zhou, Jong Bum Son, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Pageof 50